Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells

por Yvon, Eric, Vecchio, Michele Del, Savoldo, Barbara, Hoyos, Valentina, Dutour, Aurélie, Anichini, Andrea, Dotti, Gianpietro, Brenner, Malcolm K.
Publicado 2009

T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo

por Geldres, Claudia, Savoldo, Barbara, Hoyos, Valentina, Caruana, Ignazio, Zhang, Ming, Yvon, Eric, Vecchio, Michele Del, Creighton, Chad J, Ittmann, Michael, Ferrone, Soldano, Dotti, Gianpietro
Publicado 2013

miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators

por Vergani, Elisabetta, Dugo, Matteo, Cossa, Mara, Frigerio, Simona, Di Guardo, Lorenza, Gallino, Gianfrancesco, Mattavelli, Ilaria, Vergani, Barbara, Lalli, Luca, Tamborini, Elena, Valeri, Barbara, Gargiuli, Chiara, Shahaj, Eriomina, Ferrarini, Marina, Ferrero, Elisabetta, Gomez Lira, Macarena, Huber, Veronica, Vecchio, Michele Del, Sensi, Marialuisa, Leone, Biagio Eugenio, Santinami, Mario, Rivoltini, Licia, Rodolfo, Monica, Vallacchi, Viviana
Publicado en Cell Commun Signal (2020)